Ondansetron for intravenous use: New recommendations for the maximum single intravenous dose in adults


Intravenous news: MHRA report “There is new guidance for intravenous use of ondansetron in relation to: repeat dosing for all adults; dosing for prevention of chemotherapy-induced nausea and vomiting in patients age 75 years or older; and dilution and administration for patients age 65 years or older”.

Main page


Leave A Reply

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.